Washington: Johnson & Johnson has applied for a permit for the immediate use of the Kovid vaccine. It will be the third vaccine against Kovid in the United States, if approved. Pfizer-Biontech and modern vaccines were previously available in the US. Issued for distribution. It took about three weeks to approve these.
The Johnson & Johnson vaccine is unique in that a single dose is sufficient and, unlike the currently licensed vaccines, reduces the need for refrigeration.
–
– .
